alan venook, md, on potential new standard in care post approval of atezolizumab bevacizumab
Published 4 years ago • 24 plays • Length 2:16
Download video MP4
Download video MP3
Similar videos
-
2:16
alan venook, md, describes the potential practice changing results of the keynote-177 study
-
1:18
alan venook, md, on the latest in identifying valid biomarkers in the treatment of hcc
-
1:26
alan venook, md, provides thoughts on the clinical progress of trastuzumab-deruxtecan in gi cancers
-
1:05
alan p. venook, md, on integrating immunotherapy into treatment regimens for gastric cancer patients
-
5:03
atezolizumab with ebrt for bladder preservation in mibc
-
2:12
alan venook, md, considers how i-o is evolving towards the first line treatment of colorectal cancer
-
1:54
alan p. venook, md, on integrating immunotherapy into existing treatment regimens for hcc patients
-
1:39
alan venook, md, discusses next generation sequencing and mcrc treatment
-
1:23
dr. venook on immunotherapy potential in colorectal cancer
-
2:59
alan venook, md, provides opinions of the opra data in rectal cancer patients presented at asco20
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
0:52
alan p. venook, md, on identifying subgroups of hcc patients that are likely to respond to therapy
-
1:44
alan venook, md, considers how immunotherapy is being integrated into crc treatment algorithms
-
1:47
alan venook, md discusses development of immunotherapies for non msi-high crc patients
-
1:30
dr. overman on the combination of atezolizumab and bevacizumab in hcc
-
1:30
alan venook, md, discusses vemurafenib and the nccn guidelines for mcrc patients
-
1:33
alan venook, md, outlines the role of liquid biopsy in gastrointestinal cancers
-
3:08
alan venook, md, discusses uniqueness of msi-high/mismatch repair deficient crc patients
-
0:48
dr. venook discusses the future of colorectal cancer treatment
Clip.africa.com - Privacy-policy